Ergoteles LLC Ionis Pharmaceuticals Inc Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$31.71 - $43.0 $986,942 - $1.34 Million	31,124 Added 81.91%	69,124 $2.56 Million
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $897,744 - $1.11 Million	30,045 Added 377.69%	38,000 $1.41 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $1.15 Million - $1.58 Million	-44,917 Reduced 84.95%	7,955 $242,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $4.14 Million - $5 Million	-123,381 Reduced 70.0%	52,872 $1.77 Million
Q2 2021 Aug 12, 2021	BUY	$34.54 - $47.25 $6.09 Million - $8.33 Million	176,253 New	176,253 $7.03 Million
Q1 2021 May 12, 2021	SELL	$42.51 - $63.78 $2.98 Million - $4.47 Million	-70,129 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$45.3 - $60.27 $3.18 Million - $4.23 Million	70,129 New	70,129 $3.97 Million

404

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.